Disease duration and disability in dysfeRlinopathy can be described by muscle imaging using heatmaps and random forests.


Journal

Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146

Informations de publication

Date de publication:
04 2019
Historique:
received: 25 06 2018
revised: 25 11 2018
accepted: 16 12 2018
pubmed: 24 12 2018
medline: 6 7 2019
entrez: 23 12 2018
Statut: ppublish

Résumé

The manner in which imaging patterns change over the disease course and with increasing disability in dysferlinopathy is not fully understood. Fibroadipose infiltration of 61 muscles was scored based on whole-body MRI of 33 patients with dysferlinopathy and represented in a heatmap. We trained random forests to predict disease duration, Motor Function Measure dimension 1 (MFM-D1), and modified Rankin scale (MRS) score based on muscle scoring and selected the most important muscle for predictions. The heatmap delineated positive and negative fingerprints in dysferlinopathy. Disease duration was related to infiltration of infraspinatus, teres major-minor, and supraspinatus muscles. MFM-D1 decreased with higher infiltration of teres major-minor, triceps, and sartorius. MRS related to infiltration of vastus medialis, gracilis, infraspinatus, and sartorius. Dysferlinopathy shows a recognizable muscle MRI pattern. Fibroadipose infiltration in specific muscles of the thigh and the upper limb appears to be an important marker for disease progression. Muscle Nerve 59:436-444, 2019.

Identifiants

pubmed: 30578674
doi: 10.1002/mus.26403
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

436-444

Subventions

Organisme : FONDECYT
ID : FONDECYT 1151383
Pays : International

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

David Gómez-Andrés (D)

Paediatric Neurology, Vall d'Hebron University Hospital and VHIR (Euro-NMD, ERN-RND), Barcelona, Spain.

Jorge Díaz (J)

Medical Imaging Center, University of Chile Clinical Hospital, Santiago, Chile.

Francina Munell (F)

Paediatric Neurology, Vall d'Hebron University Hospital and VHIR (Euro-NMD, ERN-RND), Barcelona, Spain.

Ángel Sánchez-Montáñez (Á)

Paediatric Neuroradiology, Vall d'Hebron University Hospital (Euro-NMD, ERN-RND), Barcelona, Spain.

Irene Pulido-Valdeolivas (I)

Visual Pathway Laboratory, Neuroimmunology Center and Neurology Department, Biomedical Research Center August Pi i Sunyer (IDIBAPS), Hospital Clínic Barcelona, Spain.

Lionel Suazo (L)

Medical Imaging Center, University of Chile Clinical Hospital, Santiago, Chile.

Cristián Garrido (C)

Medical Imaging Center, University of Chile Clinical Hospital, Santiago, Chile.

Susana Quijano-Roy (S)

APHP-Neurology and Intensive Care Department. University Hospital Raymond Poincaré, Garches, U1179 Versailles University, Neuromuscular Disorders Reference Center of Nord-Est-Île de France, ERN Neuro-NMD, France.

Jorge A Bevilacqua (JA)

Neuromuscular Unit, Department of Neurology and Neurosurgery, University of Chile Clinical Hospital.
Department of Anatomy and Legal Medicine, Faculty of Medicine, University of Chile, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH